We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ANI Pharmaceuticals Inc | NASDAQ:ANIP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.14 | 0.21% | 67.25 | 63.85 | 68.71 | 67.93 | 66.6467 | 67.72 | 108,735 | 01:00:00 |
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows:
H.C. Wainwright Global Investment Conference (Virtual)
Date:
Tuesday, May 24, 2022
Time:
On Demand, 7:00 a.m. ET
Webcast:
Click Here
Jefferies Healthcare Conference (New York City, NY)
Date:
Thursday, June 9, 2022
Time:
11:30 a.m. ET
Webcast:
Click Here
The webcasts will be accessible via the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.
About ANI
ANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit www.anipharmaceuticals.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220520005082/en/
Investor Relations: Lisa M. Wilson, In-Site Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com
1 Year ANI Pharmaceuticals Chart |
1 Month ANI Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions